ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients

BACKGROUND: Receptor tyrosine-protein kinase erbB-2 (ERBB2) expression is a critical factor for the prognosis of various cancers. ERBB2 enrichment indicates a poor prognosis in some cancer types but could be a favorable prognostic factor in others. METHODS: We analyzed DNA methylation, mRNA, protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongting, Jiang, Yongxu, Jin, Huanhuan, Wang, Cunqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511046/
https://www.ncbi.nlm.nih.gov/pubmed/36172165
http://dx.doi.org/10.3389/fonc.2022.1012138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511046/
https://www.ncbi.nlm.nih.gov/pubmed/36172165
http://dx.doi.org/10.3389/fonc.2022.1012138

Ejemplares similares